Showing posts with label Hai-O. Show all posts
Showing posts with label Hai-O. Show all posts

Saturday, July 13, 2013

Consumer staples stocks

This article is contributed by a strong promoter of my blog. Read what he has to say about the consumer staples stocks in Malaysia.

The secret to successful investing is to figure out the value of something and then-pay a lot less.             
Joel Greenblatt

Whether it is economic boom or bust, people are unable or unwilling to cut out of their budgets on essential foods regardless of their financial situation. The demand of consumer staples are relatively constant, regardless of their price. Hence consumer staples stocks offer an attractive investment for investors seeking slow and steady growth.

Past growth in revenue and profitability
Table 1 at the appendix shows some of the mid and small capitalized consumer staples stocks listed in Bursa. Their past year growth, profitability and efficiencies as well as their market valuations are tabulated as shown.
Figure 1 below summaries their growth in revenue and net profit in 2012.

Figure 1: Growth in revenue and net profit


Zhulian has the fastest growth last year with revenue growing at 26%, followed by YSPSAH (15%), Haio (12%) and Apollo (11%).  Yee Lee and London Biscuits, however encountered contraction in revenue of 9% and 3% respectively. Apollo achieved the highest growth in net profit of 47%. Zhulian, Haio and Yee Lee also enjoyed good growth in net profit of 23%, 22% and 14% respectively. On the other hand, YSPSAP suffered from a contraction of its net profit due to higher tax expense. London Biscuits is the worst performer with its bottom line contracted by a huge 23%.

Profitability and operation efficiencies
In terms of net profit margin (NPM), Zhulian excels with the highest of  23%, followed by Haio and Apollo, both with double digits NPM of 15.9% and 14.4% respectively. Yee Lee has the lowest NPM of 3.1% due to its competitive environment.

The high profit margin of Zhulian in turn boasts up the return of equity (ROE) and return on invested capital (ROIC) of 26% and 39% respectively which are the highest among the companies as shown in Figure 2 below. These returns are way above its costs of capitals. Its cash return (Free Cash Flow/Invested Capital) is also remarkable at 27.5%. Zhulain is obviously has been enhancing its shareholders value greatly with these operating numbers.

Haio follows closely with respectable ROE and ROIC at 17.8% and 27% respectively. Its cash return is also as good at 27%. Apollo is also performing satisfactorily with returns above its costs of capitals.

Figure 2: Return of equity and invested capital


YSPSAP, Yee Lee and London Biscuits did not do well with their low ROE and ROIC which are below the cost of capitals . The worst performer is clearly London Biscuits with ROE and ROIC of just 4.1% and 5% respectively. It has no free cash flows at all. In fact it never seems to have any FCF for years. Wonder why it should still be in business.

Ranking
With the past year growth and the profitability and efficiencies of the companies, I would rank the companies from the best to the worst as the following Table 2:

Table 2: Ranking of companies
1
2
3
4
5
6
Zhulian
Haio
Apollo
Yee Lee
YSPSAP
LonBisc

I would expect the market to give the highest valuation for Zhulian, followed by Haio and the lowest London Biscuits. But does the market do so? Let’s look at figure 3 below.

Price-earnings ratio
I am indeed surprised that YSP is given the highest valuation with a PE ratio of 14.6, followed by Haio and Zhulian both at 13. Apollo and Yee Lee both have a PE of about 9, though Apollo’s performance appears to be much better. London Biscuit as expected ranks the lowest at 8.4, a ratio not considered really as low in view of its poor performance.

Figure 3: Market Valuation


Enterprise value
A better market valuation should be based on enterprise value over earnings before interest and tax (Ebit) for valuation of the whole firm, rather than just the equity. This is because some firms have low debt, debt free or large amount of excess cash such as Zhulian and Apollo, whereas Yee Lee has considerable amount of debt. London Biscuits’ total debts are huge.

Referring back to Figure 3 above, It is a real shocker to see that London Biscuits, being the worst in terms of growth, profitability and efficiencies, is given the highest valuation of a firm with enterprise value 11.4 times its ebit. In fact those companies with poorer performance are given higher valuations than those better ones as shown in Figure 3 above. Haio and Apollo with great performance last year, are given an enterprise value just about 6 times their ebits, or a earnings yield of about 15%.
So which company do you favour as an investment?

KC Chong (11/7/13)

Table 1: Appendix

Company
Haio
Zhulian
YSP
Yee Lee
Apollo
LonBisc
Growth Last Year
Revenue
12%
26%
15%
-9%
11%
-3%
Net profit
22%
23%
-11%
14%
47%
-23%
Profitability and efficiencies
Operating margin
21.9%
20.9%
12.0%
4.5%
19%
11.3%
Net profit margin
15.9%
26.0%
7.5%
3.1%
14.4%
5.4%
Return of assets
13.9%
22.1%
4.6%
4.1%
12.5%
2.2%
Return of Equity
17.8%
25.9%
6.2%
7.6%
13.9%
4.1%
Return on invested capital
29.1%
39.1%
6.4%
7.0%
17.6%
5.0%
FCF/IC
27.1%
27.5%
-1%
16%
13.8%
NA
Market valuations
Price on 11/7/13
2.70
3.17
1.49
1.32
4.09
0.685
PE ratio
12.8
12.5
14.6
10.5
10.3
8.4
EV/Ebit
6.9
8.5
8.7
8.8
5.8
11.4

Monday, January 7, 2013

Is Hai-O picking itself back?

I remember as a kid walking into a Hai-O shop near the place I stayed - it is one of the few big enough retail outlets to have air-conditions. The company has since then grown so much although I would not know where it was positioned about 35 years ago. Hai-O is a story about two things - chinese medicinal products and turning them into a MLM business. Both of them have one trait - high profits margin if executed well.

It was probably having that high margin trait many years ago and today it is the same. Ever notice, among the ones that are still surviving in our neighborhood are the chinese medicinal shops. All the other types of groceries are now dead - killed by the Tesco(s), the Giant(s), the AEON(s). Chinese medicinal shops however are still around - something that the above names would not be able to kill yet. If I am a consultant to these hypermarket giants, I would advice them to offer a specialized unit selling these products, would have a growth factor there, I would think. The margin is fantastic as well.

Anyway, among the many - Hai-O has moved one step further - MLM. Over the years, it has managed to build that business to a big factor to its business. It is amazing what business people can make out of health products through MLM. The things that Hai-O is doing since it is in the consumer products space is supposed to be stable, consistent, and defensive. There should have been some level of consistencies. But...

5-year highlight between 2008 to 2012
Anyone can let me know the reason behind the huge drop between 2010 and 2011? I am thinking, as an investor, if I were to buy its shares in 2009, today I must have been really pissed off. Not by the one or two missteps in pricing, economic downturn or anything of that sort, but from revenue? To me how can medicinal products have such drops.

Let's look at several other indicators. The best revenue year was 2010 and if it is doing well, its MLM is the major contributor. Other segment - manufacturing and retail are pretty consistent. Notice the wholesale is basically supporting the MLM to a certain extent.

2010 segmental report for revenue
On a worse year - say in 2011, its MLM is the less performing one. From 2010 to 2011, the MLM's revenue basically dropped 70%. Seriously, I can't explain or imagine how can such a drop happened. It feels like the group has lost more than half of its performing MLM agents whom have moved into promoting some other people's products. MLM guys - can this happen?

2011 segmental report
If you notice, the net profit margin is consistently between 13% to 17%. That's the consistent part. The volatility in revenue performance which trickle down to the net profit though affected its share price. Look at where it peaked after the huge run between 2008 to 2010. The only thing I can speculate is people started to eat more medicinal products during hard times or more people moving into second job- MLM during the harder times of 2008 to 2009?



Anyway, as I see it for 2012 and half of FY2013 its business started to pick up. Would it surprise again is the question...